Blog Post
Going Global with Electronic Systems: What Cross-Border Data Privacy Really Requires
Loading…
Sara Saunders
Director of Global Regulatory Affairs
Electronic systems have transformed clinical research. eISF, eTMF, eConsent, and remote monitoring tools let sponsors and sites move faster, reduce paper burden, and keep studies running smoothly across borders. But global reach brings a regulatory reality that’s easy to underestimate, the moment personal data crosses a border, new rules apply.
Getting this right isn’t about slowing down. It’s about knowing what to check before you start, so your study never has to pause.
Know Where Your Users Are
Before deploying any system, one question deserves just as much attention as whether it works, and that’s understanding where this data will actually live and where it’s going.
The location of your users and trial participants determines which transfer rules apply. A site in Germany, Singapore, or Brazil each triggers a different set of regional data protection requirements. Under the EU GDPR, for example, transfers of personal data outside the European Economic Area are only permitted under specific legal mechanisms set out in Chapter V, such as an adequacy decision or Standard Contractual Clauses. Skipping this step at the outset is one of the most common (and most avoidable) missteps in global trial planning.
Know Where Your Data Goes
It’s not enough to know where your users are. You also need to know where their data ends up, including:
- Primary data centers processing and storing study data
- Backup and disaster recovery centers, which may be in a different country than the primary center and easy to overlook
- Subprocessors or third-party services the platform relies on behind the scenes
A vendor should be able to tell you exactly where data resides at every stage, not just where it starts.
Consent Comes First
Users of electronic systems often consent to global data flows by logging into a system and accepting its terms and conditions. But not every clinical trial participant logs into the system managing their data. In many cases, a participant’s health information is uploaded into a system being used for the study, without the participant ever logging into it themselves. In these cases, consent typically needs to come from the clinical trial consent form itself, before that information is uploaded and processed.
Either way, if a user is logging into a system directly, or their data is being uploaded into one, consent needs to be secured before that data flows to an electronic system or crosses any border. This isn’t just good practice. It’s often a legal requirement tied to the specific transfer mechanism relied upon. Consent obtained after the data has already moved doesn’t meet privacy requirements, and it leaves the study in a difficult position.
Many Countries Add Their Own Requirements
Beyond the core question of “can data leave the region,” individual countries frequently layer on their own regulatory requirements, such as:
- Data Protection Impact Assessments (DPIAs), such as those required under GDPR Article 35 for processing likely to result in high risk to individuals
- Local registration or notification requirements with national data protection authorities
- Data localization provisions that restrict certain data from leaving the country at all
None of these are deal-breakers. But they do need to be identified early, mapped to the specific system and study design, and built into the plan from day one.
It Sounds Like a Lot. It Doesn’t Have to Be.
Taken individually, these considerations, participant location, data residency, backup centers, consent timing, and country-specific rules, sound like a heavy lift. Taken together, they’re exactly why the vendor you choose matters as much as the platform itself.
The right partner has already done this work. They understand what it takes to operate a platform at global scale and can walk into a conversation about a new country or region with answers, not open questions.
Florence is Here to Help
At Florence, this is built into how we operate. We support studies globally and maintain global data center infrastructure designed to help sponsors and sites meet their cross-border transfer requirements with confidence, not guesswork.
Going global with your clinical trial technology shouldn’t mean navigating cross-border privacy alone. It should mean partnering with a vendor who’s already mapped the terrain.